IGF-1 treatment increases the mitochondrial mass (Lyons et al., 2017) and PGC-1β expression (Chang et al., 2011; Lyons et al., 2017) in human breast cancer cells through activation of PI3K. The gene discussed is IGF1; the disease is breast cancer.